Systemic administration of reovirus (Reolysin) inhibits growth of human sarcoma xenografts.
about
Clinical development of reovirus for cancer therapy: An oncolytic virus with immune-mediated antitumor activityCancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advancesOncolytic virotherapy for pediatric malignancies: future prospectsActivation of p53 by chemotherapeutic agents enhances reovirus oncolysisTargeting pediatric cancer stem cells with oncolytic virotherapyA phase I trial and viral clearance study of reovirus (Reolysin) in children with relapsed or refractory extra-cranial solid tumors: a Children's Oncology Group Phase I Consortium reportBone Sarcomas in Pediatrics: Progress in Our Understanding of Tumor Biology and Implications for Therapy.Progress of oncolytic viruses in sarcomas.The adolescent and young adult with cancer: state of the art -- bone tumors.Vesicular stomatitis virus has extensive oncolytic activity against human sarcomas: rare resistance is overcome by blocking interferon pathways.HIF-1α downregulation and apoptosis in hypoxic prostate tumor cells infected with oncolytic mammalian orthoreovirus.Downregulation of key regulatory proteins in androgen dependent prostate tumor cells by oncolytic reovirus.Oncolytic virus therapy for cancer.Reolysin and Histone Deacetylase Inhibition in the Treatment of Head and Neck Squamous Cell Carcinoma.Attack of the cancer-killing viruses: clinical application of oncolytic virotherapy in children.Simultaneously double infection of oncolytic viruses leads to addition of cell death induction in glioblastoma cell lines.
P2860
Q26750568-298660EE-8ABD-4D83-933F-F250D384A57FQ26863779-E6706BC0-852B-4601-9936-C5179EFA9067Q28069358-E3BE885D-D650-415F-9F04-5EDA14BE6FFBQ28485141-745A4DF8-3176-4966-925E-A55CA006F83FQ34262327-D6867968-4855-4BA5-B879-6B498CB3CD84Q35224368-23CBC2A7-5B98-4C63-BA97-968AB437383AQ35894540-7DD37207-9B26-4512-920B-E25298A6EA07Q37982449-B104D0CB-8661-495F-B12A-674415FE6DB5Q38108248-6343830D-72D5-4CE5-878E-AB5977DC18CDQ38286116-B9B7A1E1-DB6F-43E9-9774-B6BA0DB80CF8Q38458133-AD8042FD-BD2F-4AE1-9D7C-AFB3C7C06173Q38844346-2BF73C69-D2D3-4B4E-A168-115DB63C65FEQ38924529-36A87F0E-72F4-4851-8603-CE4D126B5EE0Q40081751-292D7860-4D40-498A-864A-D9A42D735092Q42170507-902E9E4C-F751-4FAE-8ADD-044AEB1E9095Q46734231-C2F0A4B2-A1B2-4C98-8764-03BBC39C9393
P2860
Systemic administration of reovirus (Reolysin) inhibits growth of human sarcoma xenografts.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Systemic administration of reo ...... h of human sarcoma xenografts.
@en
Systemic administration of reovirus
@nl
type
label
Systemic administration of reo ...... h of human sarcoma xenografts.
@en
Systemic administration of reovirus
@nl
prefLabel
Systemic administration of reo ...... h of human sarcoma xenografts.
@en
Systemic administration of reovirus
@nl
P2093
P2860
P356
P1433
P1476
Systemic administration of reo ...... h of human sarcoma xenografts.
@en
P2093
Chandan Guha
E Anders Kolb
Laibin Liu
Pooja Hingorani
Wendong Zhang
P2860
P304
P356
10.1002/CNCR.25741
P407
P577
2010-11-08T00:00:00Z